Evidence map›Paper›PMID 39614344›Full record

ArticleTranslational neurodegeneration2024

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.

Nerea Gómez de San José, Steffen Halbgebauer, Petra Steinacker, Sarah Anderl-Straub, Samir Abu-Rumeileh, Lorenzo Barba, Patrick Oeckl, Giovanni Bellomo, Lorenzo Gaetani, Andrea Toja and 8 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational neurodegeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Aquaporin-4 in Stroke and Brain Edema-Friend or Foe?International journal of molecular sciences · 2025
    Review
  5. Biomarkers of blood-brain barrier and neurovascular unit integrity in human cognitive impairment and dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Nerea Gómez de San José *Department of Neurology, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Steffen Halbgebauer *Department of Neurology, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Petra SteinackerDepartment of Neurology, University Clinic, University Hospital Halle, Martin Luther University, Ernst-Grube Strasse 40, 06120, Halle (Saale), Germany.
Sarah Anderl-StraubDepartment of Neurology, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Samir Abu-RumeilehDepartment of Neurology, University Clinic, University Hospital Halle, Martin Luther University, Ernst-Grube Strasse 40, 06120, Halle (Saale), Germany.
Lorenzo BarbaDepartment of Neurology, University Clinic, University Hospital Halle, Martin Luther University, Ernst-Grube Strasse 40, 06120, Halle (Saale), Germany.
Patrick OecklDepartment of Neurology, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.
Giovanni BellomoSection of Neurology, Department of Medicine and Surgery, University of Perugia, Piazza dell'Università, 1, 06123, Perugia, Italy.
Lorenzo GaetaniSection of Neurology, Department of Medicine and Surgery, University of Perugia, Piazza dell'Università, 1, 06123, Perugia, Italy.
Andrea TojaSection of Neurology, Department of Medicine and Surgery, University of Perugia, Piazza dell'Università, 1, 06123, Perugia, Italy.
Sára MravinacováDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Brinellvägen 8, 114 28, Stockholm, Sweden.
Sofia BergströmDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Brinellvägen 8, 114 28, Stockholm, Sweden.
Anna MånbergDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Brinellvägen 8, 114 28, Stockholm, Sweden.
Alberto GrassiniDepartment of Neuroscience, "Rita Levi Montalcini", University of Torino, Via Cherasco 15, 10126, Turin, Italy.
Innocenzo RaineroDepartment of Neuroscience, "Rita Levi Montalcini", University of Torino, Via Cherasco 15, 10126, Turin, Italy.
Peter NilssonDepartment of Protein Science, SciLifeLab, KTH Royal Institute of Technology, Brinellvägen 8, 114 28, Stockholm, Sweden.
Lucilla ParnettiSection of Neurology, Department of Medicine and Surgery, University of Perugia, Piazza dell'Università, 1, 06123, Perugia, Italy.
Markus OttoDepartment of Neurology, University Clinic, University Hospital Halle, Martin Luther University, Ernst-Grube Strasse 40, 06120, Halle (Saale), Germany. markus.otto@uk-halle.de.ORCID http://orcid.org/0000-0003-4273-4267

Funding

European Union-Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN PNRR-MAD-2022-12376035HORIZON EUROPE Marie Sklodowska-Curie Actions 860197Medical Faculty of Martin-Luther University Halle-Wittenberg (Clinician Scientist-Programm) CS22/06Medical Faculty of Martin-Luther University Halle Wittenberg (Junior Clinician Scientist Programm) JCS24/02Postdoctoral Fellowship for Basic Scientists grant of the Parkinson's Foundation PF-PRF-934916the European Union-Next Generation EU - PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN PNRR-MAD-2022-12376035
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39614344
PMCPMC11606142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.